Summary
Cytochrome P-450 dependent oxygenase (3′-hydroxy-hexobarbital) and oxidase activities (hydrogen peroxide) have been measured in hepatic microsomes from guinea pigs, rats and rabbits. A sensitive gas-chromatographic assay was developed to measure the hydroxylated product 3′-hydroxy-hexobarbital. The kinetics of its formation were determined and correlated to hexobarbital type I binding and compared with oxidase activity: in the rat, V max for 3′-hydroxy-hexobarbital formation and for hexobarbital-dependent H2O2 formation was 5.1 and 2.6 nmoles/mg/min, resp. This was increased by phenobarbital tratment to 15.2 and 13.4 nmoles/mg/min. In phenobarbital treated rabbits, V max was 15.0 nmoles/mg/min for hydroxylation and 40.8 for H2O2 formation. Spectral affinity constants (K s) in control animals were 0.12 mM (rats) and 0.14 mM (rabbits). Phenobarbital treatment decreased these affinity constants, which were similar for each activity measured. In guinea pigs, however, hydroxylation of hexobarbital was low (3.1 nmoles/mg/min) and hexobarbital-dependent formation of H2O2 was higher than hydroxylation (V max:7.0 nmoles/mg/min). Phenobarbital treatment led here to two affinity constants for each activity measured, which however, were alike. The existence of low in addition to high affinity constants observed here might explain the difficulties seen hitherto in correlating hexobarbital binding and metabolism in this species. Total oxidase activity was higher than oxygenase activity in all species tested.
It is suggested that oxygenase activity of cytochrome P-450 is not limited by binding but by a competition with oxidase activity for a common intermediary species. This might be peroxy-P-450 (substrate-Fe3+O2 2−), rendering either substrate-Fe3+O for hydroxylation reaction, or oxidized cytochrome P-450-substrate and hydrogen peroxide as product of oxidase function.
Similar content being viewed by others
Abbreviations
- S:
-
substrate
- PB:
-
phenobarbital
- HB:
-
hexobarbital
- 3-OH-HB:
-
3′-hydroxy-hexobarbital
- DPH:
-
diphenylhydantoin
References
Breimer DD, van Rossum JM (1974) Pharmacokinetics of the enantiomers of hexobarbital in the same rat and in the same perfused rat liver. Eur J Pharmacol 26:321–330
Bush MT, Weller H (1973) The metabolic fate of hexobarbital. In: Di Carlo FJ (ed) Drug metabolism reviews, vol 1, Dekker, Inc., New York, pp 249–290
Cooper JR, brodie BB (1955) The enzymatic metabolism of hexobarbital. J Pharmacol Exp Ther 114:409–417
Degkwitz E, Ullrich V, Staudinger HJ, Rummel W (1969) Metabolism and cytochrome P-450 binding spectra of (+) and (−) hexobarbital in rat liver microsomes. Hoppe Seylers Z Physiol Chem 350:547–553
Dixon M, Webb EC (1979) Enzymes. Longman group Ltd, London, 3rd edition, pp 75–78
Estabrook RW, Werringloer J (1977) Active oxygen — fact of fancy. In: Ullrich V, Roots I, Hildebrandt AG, Estabrook RW Conney AH (eds) Microsomes and drug oxidations. Pergamon Press, New York, pp 748–757
Estabrook RW, Werringloer J (1978) Chairman's introductory statement: The microsomal enzyme system responsible for the oxidative metabolism of many drugs. In: Estabrook RW, Lindenlaub E (eds) The induction of drug metabolism. Symposia Med. Hoechst Vol 14. Schattauer Verlag, Stuttgart New York, pp 187–199
Estabrook RW, Kawano S, Werringloer J, Kuthan H, Tsuji H, Graf H, Ullrich V (1979) Oxycytochrome P-450: Its breakdown to superoxide for the formation of hydrogen peroxide. Acta Biol Med Ger 38:423–434
Feller DR, Lubaway WC (1973) Interaction of hexobarbital enantiomers with rat liver microsomes. Pharmacology 9:129–137
Gillette JR (1969) Mechanisms of the oxidation by enzymes in the endoplasmic reticulum. In: Shugar D (ed) Biological aspects of antimetabolites and of drug hydroxylation. FEBS Meeting Prague 1968, vol 16. Academic Press, New York, pp 109–124
Gillette JR, Sasame H, Stripp B (1973) Mechanisms of inhibition of drug metabolic reactions. Drug Metab Dispos 1:164–175
Gundermann K, Degkwitz E, Staudinger HJ (1973) Mischfunktionelle Oxygenierung von (+) und (−) Hexobarbital und spektrale Änderungen des Cytochroms P-450 in der Leber ascorbinsäurefrei ernährter Meerschweinchen. Hoppe Seylers Z Physiol Chem 354:238–242
Harvey DJ, Glazener L, Johnson DB, Butler CM, Horning MG (1977) Comparative metabolism of four allylic barbiturates and hexobarbital by the rat and guinea pig. Drug Metab Dispos 5:527–546
Hildebrandt AG, Speck M, Roots I (1973) Possible control of hydrogen peroxide production and degradation in microsomes during mixed function oxidation reactions. Biochem Biophys Res Comm 54:968–975
Hildebrandt AG, Heinemeyer G, Roots I, Nigam S (1978a) Regulation of mechanism of oxygen and substrate function in hepatic microsomes. 7th Int Congress of Pharmacol, Paris, Abstract
Hildebrandt AG, Roots I, Tjoe M, Heinemeyer G (1978b) Hydrogen peroxide in hepatic microsomes. In: Fleischer S, Packer L (eds) Methods in enzymology, vol LII. Academic Press, New York, pp 342–350
Hildebrandt AG, Heinemeyer G, Nigam S, Roots I (1980) Substrate and oxygen activation during hexobarbital metabolism. In: Coon MJ, Conney AH, Estabrook RW, Gelboin HV, Gillette JR, O'Brien PL (eds) Microsomes, drug oxidations and chemical carcinogenesis. Academic Press, New York, pp 335–338
Hogeboom GH (1955) Fractionation of cell components of animal tissue. In: Colowick SP, Kaplan NO (eds) Methods in enzymology, vol I. Academic Press, New York, pp 16–19
Holtzman JL, Rumack BH (1973) Kinetic studies on the control of ethylmorphine N-demethylase. The role of ethylmorphine activation of reduced nicotinamid-adenin-dinucleotide phosphate-cytochrome P-450 reductase. Biochemistry 12:2309–2313
Kageura E, Toki S (1971) New aspect of guinea pig 17-β-hydroxysteroid dehydrogenase. Life Sci 10:469–474
Kato R, Onoda K, Sasajima M (1970) Effects of morphine treatment and starvation on the substrate interaction with P-450 in the oxidation of drugs by liver microsomes. Jpn J Pharmacol 20:194–209
Koeppe P, Hamann C (1978) Zwei Methoden zur Parameterschätzung nichtlinearer Regressionsfunktionen bei fehlerhaften Meßdaten. EDV Med Biol 9:112–117
Kupfer D (1978) Assay of hexobarbital hydroxylase. Drug Metab Dispos 6:610
Kupfer D, Rosenfeld J (1973) A sensitive radioactive assay for hexobarbital hydroxylase in hepatic microsomes. Drug Metab Dispos 1:760–765
Least CJ, Johnson GF, Solomon HM (1977) Micro-scale anticonvulsant assay with use of nitrogen/phosphorus detector and on-column methylation compared with a macro-scale procedure involving flame ionisation detection. Clin Chem 23:593–595
Nash T (1955) The colorimetric estimation of formaldehyde by means of the Hantzsch reaction. Biochem J 55:416–421
Noordhoek J, Van den Berg AP, Saveninje-Chapel EM, Koopman-Kool E (1977) Metabolism of hexobarbital enantiomers and interaction with cytochrome P-450 in male and female mice and rats. In: Ullrich V, Roots I, Hildebrandt AG, Estabrook RW, Conney AH (eds) Microsomes and drug oxidations, Pergamon Press, New York, pp 534–542
Nordblom GD, Coon MJ (1977) Hydrogen peroxide formation and stoichiometry of hydroxylation reactions catalyzed by highly purified liver microsomal cytochrome P-450. Arch Biochem Biophys 180:343–347
Quinn GP, Axelrod J, Brodie BB (1958) Species, strain and sex differences in metabolism of hexobarbitone, aminopyrine, antipyrine and anilin. Biochem Pharmacol 1:152–159
Roots I, Laschinsky G, Hildebrandt AG, Heinemeyer G, Nigam S (1980) Inhibition of hexobarbital-induced microsomal H2O2-production by metyrapone. In: Coon MJ, Conney AH, Estabrook RW, Gelboin HV, Gillette JR, O'Brien PJ (eds) Microsomes, drug oxidations, and chemical carcinogenesis. Academic Press, New York, pp 375–378
Sato R, Imai Y, Taniguchi H (1978) Reaction mechanism of liver microsomal cytochrome P-450 as studied by reconstitution techniques. In: Estabrook RW, Lindenlaub E (eds) The induction of drug metabolism. Symposia Med. Hoechst vol 14, Schattauer Verlag, Stuttgart New York, pp 213–223
Schenkman JB, Remmer H, Estabrook RW (1967) Spectral studies of drug interaction with hepatic microsomal cytochrome. Mol Pharmacol 3:113–123
Sitar DS, Mannering GJ (1973) Determination of apparent kinetic constants of the microsomal hydroxylation of amobarbital, hexobarbital and pentobarbital. Drug Metab Dispos 1:663–668
Steinbach H, Gielen W (1977) Gaschromatographische Bestimmung von hexobarbital und seines Metaboliten aus biologischem Material. J Chromat 139:191–194
Tsukamoto H, Yoshimura H, Toki S (1956) Metabolism of drugs. VI: The metabolic fate of methylhexabital (5-cyclohexenyl-5-dimethylbarbituric acid). Chem Pharm Bull (Tokyo) 4:364–367 Chem Abstr 51:8980a
Ullrich V, Schädelin J, Staudinger HJ (1969) Hydroxylation and substrate binding of cyclohexane by liver microsomes. In: Shugar D (ed) Biochemical aspects of antimetabolites and of drug hydroxylation. FEBS meeting, Prague 1968, Vol 16. Academic Press, New York, pp 261–265
Vermeulen NPE, Bakker BH, Schultink J, Van der Gen A Breimer DD (1979) The epoxide diol pathway in the metabolism of hexobarbital in rat and man. Xenobiotika 9:289–299
Yoshimura H (1958) Metabolism of drugs. XVI. The metabolic fate of metylhexabital (5-cyclohexenyl-3,5-dimethylbarbituric acid). (6. Studies on the reduction of 3-keto-MHB (5-(3-oxo-1-cyclohexenyl)-3,5-dimethylbarbituric acid) and on pharmacological activity of the biotransformation products of methylhexabital from the urine of rabbits). Chem Pharm Bull (Tokyo) 6:13–14
Author information
Authors and Affiliations
Additional information
Supported in part by the Deutsche Forschungsgemeinschaft, Grant Hi 156/2, Biochemische Grundlagen der Arzneimittel- und Fremdstoffwirkungen
Rights and permissions
About this article
Cite this article
Heinemeyer, G., Nigam, S. & Hildebrandt, A.G. Hexobarbital-binding, hydroxylation and hexobarbital-dependent hydrogen peroxide production in hepatic microsomes of guinea pig, rat and rabbit. Naunyn-Schmiedeberg's Arch. Pharmacol. 314, 201–210 (1980). https://doi.org/10.1007/BF00504539
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00504539